Company / Current Assets
Moderna Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$6.5B
FY2025
5-year range
$6.5B / $16.1B
FY2021-FY2025
Trend
-19.2%
vs FY2024
Sector context
#15 of 213
Health Care
What the data says
Among 213 Health Care companies, Moderna is in the top 7% for current assets. Current Assets has declined for 4 consecutive years, from $16.1B in FY2021 to $6.5B in FY2025.
Based on SEC 10-K filings.
$6.5B in FY2025 with a 5-year CAGR of +0.8%. Top quartile in the Health Care sector.
Declined from $10.3B to $6.5B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -21.3%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 213This company $6.5B Sector average $2.5B
▼
+159.4% above sector average
Key checks
Key Insights
- Moderna's current assets has declined for 4 consecutive years.
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, current assets decreased 19.2% year-over-year.
- Ranks #15 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.5B | -19.2% |
| FY2024 | $8.1B | -21.6% |
| FY2023 | $10.3B | -23.1% |
| FY2022 | $13.4B | -16.4% |
| FY2021 | $16.1B | +155.2% |
| FY2020 | $6.3B | +457.9% |
| FY2019 | $1.1B | -27.8% |
| FY2018 | $1.6B | +99.6% |
| FY2017 | $783.2M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026